Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cheung

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Current Oncology Reports|March 29, 2019
Trends in Management of Oligometastatic Hormone-Sensitive Prostate CancerGargi Kothari, Piet Ost, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2024
Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective ReviewGeorge J Li, Hendrick Tan, Humza Nusrat, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of lifeGerard C Morton, D Andrew Loblaw, Raxa Sankreacha, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2022
Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation TherapyEric K Nguyen, Ian Poon, Yee C Ung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
Journal of Thoracic Disease|July 10, 2020
Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic reviewMichael C Tjong, Nauman H Malik, Hanbo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2025
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric AnalysisGeorge J Li, Melissa Sam Soon, Hanbo Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2021
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication mattersHendrick Tan, Patrick Cheung, Alexander V Louie, et al.
Cancers|July 29, 2025
CT-Based Radiomics for <i>a priori</i> Predicting Response to Chemoradiation in Locally Advanced Lung AdenocarcinomaErika Z Chung, Laurentius O Osapoetra, Patrick Cheung, et al.
Scientific Reports|March 7, 2018
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapyAnastasia Oikonomou, Farzad Khalvati, Pascal N Tyrrell, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Current Oncology Reports|March 29, 2019
Trends in Management of Oligometastatic Hormone-Sensitive Prostate CancerGargi Kothari, Piet Ost, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2024
Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective ReviewGeorge J Li, Hendrick Tan, Humza Nusrat, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of lifeGerard C Morton, D Andrew Loblaw, Raxa Sankreacha, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2022
Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation TherapyEric K Nguyen, Ian Poon, Yee C Ung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
Journal of Thoracic Disease|July 10, 2020
Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic reviewMichael C Tjong, Nauman H Malik, Hanbo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2025
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric AnalysisGeorge J Li, Melissa Sam Soon, Hanbo Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2021
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication mattersHendrick Tan, Patrick Cheung, Alexander V Louie, et al.
Cancers|July 29, 2025
CT-Based Radiomics for <i>a priori</i> Predicting Response to Chemoradiation in Locally Advanced Lung AdenocarcinomaErika Z Chung, Laurentius O Osapoetra, Patrick Cheung, et al.
Scientific Reports|March 7, 2018
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapyAnastasia Oikonomou, Farzad Khalvati, Pascal N Tyrrell, et al.
Pageof 15